04:28 PM EST - BioMS Medical Corp : said on Friday it has received U.S. Food and Drug Administration approval to begin a Phase 3 trial of its multiple sclerosis treatment.Giese said the trial of its treatment for secondary progressive MS is expected to be completed by the end of 2009, with market approval expected about a year later. BioMS Medical Corp
shares T.MS are trading up 13 cents at $3.68.
